PROBENECID W/ COLCHICINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Probenecid W/ Colchicine, and when can generic versions of Probenecid W/ Colchicine launch?
Probenecid W/ Colchicine is a drug marketed by Lederle and Watson Labs and is included in two NDAs.
The generic ingredient in PROBENECID W/ COLCHICINE is colchicine; probenecid. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colchicine; probenecid profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROBENECID W/ COLCHICINE?
- What are the global sales for PROBENECID W/ COLCHICINE?
- What is Average Wholesale Price for PROBENECID W/ COLCHICINE?
Summary for PROBENECID W/ COLCHICINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Clinical Trials: | 2 |
| DailyMed Link: | PROBENECID W/ COLCHICINE at DailyMed |
Recent Clinical Trials for PROBENECID W/ COLCHICINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Chinese University of Hong Kong | Phase 2 |
| Mutual Pharmaceutical Company, Inc. | Phase 1 |
US Patents and Regulatory Information for PROBENECID W/ COLCHICINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lederle | PROBENECID W/ COLCHICINE | colchicine; probenecid | TABLET;ORAL | 086954-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | PROBENECID W/ COLCHICINE | colchicine; probenecid | TABLET;ORAL | 083221-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
